Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis
Abstract We explore the association between three Alzheimer’s disease-related and ten inflammation-related CSF markers and freezing of gait (FOG) in patients with Parkinson’s disease (PD). The study population includes PD patients with FOG (PD-FOG, N = 12), without FOG (PD-NoFOG, N = 19), and health...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/924d91281f934f699f164f0dae6b1608 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:924d91281f934f699f164f0dae6b1608 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:924d91281f934f699f164f0dae6b16082021-12-05T12:17:22ZCerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis10.1038/s41531-021-00247-x2373-8057https://doaj.org/article/924d91281f934f699f164f0dae6b16082021-11-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00247-xhttps://doaj.org/toc/2373-8057Abstract We explore the association between three Alzheimer’s disease-related and ten inflammation-related CSF markers and freezing of gait (FOG) in patients with Parkinson’s disease (PD). The study population includes PD patients with FOG (PD-FOG, N = 12), without FOG (PD-NoFOG, N = 19), and healthy controls (HC, N = 12). Age and PD duration are not significantly different between groups. After adjusting for covariates and multiple comparisons, the anti-inflammatory marker, fractalkine, is significantly decreased in the PD groups compared to HC (P = 0.002), and further decreased in PD-FOG compared to PD-NoFOG (P = 0.007). The Alzheimer’s disease-related protein, Aβ42, is increased in PD-FOG compared to PD-NoFOG and HC (P = 0.001). Group differences obtained in individual biomarker analyses are confirmed with multivariate discriminant partial least squares regression (P < 0.001). High levels of Aβ42 in PD-FOG patients supports an increase over time from early to advanced state. Low levels of fractalkine might suggest anti-inflammatory effect. These findings warrant replication.J. M. Hatcher-MartinJ. L. McKayA. F. PybusB. SommerfeldJ. C. HowellF. C. GoldsteinL. WoodW. T. HuS. A. FactorNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-7 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurology. Diseases of the nervous system RC346-429 J. M. Hatcher-Martin J. L. McKay A. F. Pybus B. Sommerfeld J. C. Howell F. C. Goldstein L. Wood W. T. Hu S. A. Factor Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis |
description |
Abstract We explore the association between three Alzheimer’s disease-related and ten inflammation-related CSF markers and freezing of gait (FOG) in patients with Parkinson’s disease (PD). The study population includes PD patients with FOG (PD-FOG, N = 12), without FOG (PD-NoFOG, N = 19), and healthy controls (HC, N = 12). Age and PD duration are not significantly different between groups. After adjusting for covariates and multiple comparisons, the anti-inflammatory marker, fractalkine, is significantly decreased in the PD groups compared to HC (P = 0.002), and further decreased in PD-FOG compared to PD-NoFOG (P = 0.007). The Alzheimer’s disease-related protein, Aβ42, is increased in PD-FOG compared to PD-NoFOG and HC (P = 0.001). Group differences obtained in individual biomarker analyses are confirmed with multivariate discriminant partial least squares regression (P < 0.001). High levels of Aβ42 in PD-FOG patients supports an increase over time from early to advanced state. Low levels of fractalkine might suggest anti-inflammatory effect. These findings warrant replication. |
format |
article |
author |
J. M. Hatcher-Martin J. L. McKay A. F. Pybus B. Sommerfeld J. C. Howell F. C. Goldstein L. Wood W. T. Hu S. A. Factor |
author_facet |
J. M. Hatcher-Martin J. L. McKay A. F. Pybus B. Sommerfeld J. C. Howell F. C. Goldstein L. Wood W. T. Hu S. A. Factor |
author_sort |
J. M. Hatcher-Martin |
title |
Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis |
title_short |
Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis |
title_full |
Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis |
title_fullStr |
Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis |
title_full_unstemmed |
Cerebrospinal fluid biomarkers in Parkinson’s disease with freezing of gait: an exploratory analysis |
title_sort |
cerebrospinal fluid biomarkers in parkinson’s disease with freezing of gait: an exploratory analysis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/924d91281f934f699f164f0dae6b1608 |
work_keys_str_mv |
AT jmhatchermartin cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT jlmckay cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT afpybus cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT bsommerfeld cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT jchowell cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT fcgoldstein cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT lwood cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT wthu cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis AT safactor cerebrospinalfluidbiomarkersinparkinsonsdiseasewithfreezingofgaitanexploratoryanalysis |
_version_ |
1718372087681253376 |